A retrospective study to assess use of Blinatumomab in pediatric relapsed and refractory acute lymphoblastic leukemia patients
Latest Information Update: 10 Feb 2021
At a glance
- Drugs Blinatumomab (Primary)
- Indications Precursor B-cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 10 Feb 2021 New trial record